Pharmaceutical Executive
September 01, 2013
Column
0
0
What does a challenger brand need to do?
September 01, 2013
Features
0
0
The Sunshine Act's Open Payments spending disclosure program is now live. The government's lead compliance officer explains how it will work.
September 01, 2013
Column
0
0
Companies are leveraging combinations of drugs and other products to gain competitive advantage and market share.
September 01, 2013
Column
0
0
Are electronic health records a viable channel for engagement? Ben Comer reports.
September 01, 2013
From the Editor
0
0
A key issue for biopharma marketers today is balancing cost and value factors around specialty biologic drugs, particularly those for cancer and other high profile, lifealtering diseases.
September 01, 2013
Column
0
0
Rising costs will mean a drop in anticipated NDAs next year, reflecting an ever-longer and more costly drug-development process that is squeezing pharma investment in R&D.
September 01, 2013
Column
0
0
With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided.
September 01, 2013
Country Report
0
0
Ask Indonesians about a bad experience in medical care and each will have a story to tell. The poor state of Indonesia's healthcare system has turned "improving quality" into the top priority of the government of Indonesia. Better quality of care has become especially important as the fourth most populated country in the world moves forward with its plans to achieve universal healthcare coverage.
September 01, 2013
Features
0
0
Normal service will be resumed as soon as possible.
September 01, 2013
Column
0
0
By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.